Treatment of an ocular squamous cell carcinoma in a stallion with atrial fibrillation.

This research paper discusses the surgical treatment of an eye cancer, specifically limbal squamous cell carcinoma, in a stallion (male horse) concurrently suffering from atrial fibrillation, a heart disorder. The heart disorder complicated treatment because the medicine typically used could potentially introduce other complications.

About the Case

• The study is based on a case of a stallion that was diagnosed with an ocular disorder, known as limbal squamous cell carcinoma.
• This is a form of cancer that affects the eye. Specifically, it develops in the limbus, which is the border area between the clear cornea at the front of the eye and the white sclera – the outer layer of the eye.

Surgical Treatment

• The stallion was presented for surgical treatment of this cancer. The chosen method of treatment was to excise the cancerous tissues.
• In order to prevent the cancer from spreading into the eye and to preserve the animal’s vision, a surgical technique called a conjunctival pedicle flap was performed after the excision.
• This technique involves creating a flap of healthy tissue from the conjunctiva – the clear tissue covering the white part of the eye, and using it to repair the area where the cancer has been removed.

Complication of the Case

• A complication of this case was that the stallion was also diagnosed with a heart disorder called atrial fibrillation. This is a condition characterized by irregular, often rapid heart rate that can lead to poor blood flow to the body.
• Under normal circumstances, atrial fibrillation can be treated and converted back to normal heart rhythm (sinus rhythm) using a medication called quinidine sulfate.
• However, in this case, the treatment could not be given due to the potential for it to cause complications in combination with the surgical treatment for the eye cancer.

Conclusion

• This case highlights the potential challenges of treating ocular squamous cell carcinoma in horses that have other underlying health conditions. In this scenario, the presence of atrial fibrillation complicated the treatment protocol, dictating a more cautious approach in managing the patient’s health.